Cutler Group’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,400
| Closed | -$3K | – | 5844 |
|
|
2022
Q2 | $3K | Hold |
2,400
| – | – | ﹤0.01% | 4189 |
|
|
2022
Q1 | $2K | Hold |
2,400
| – | – | ﹤0.01% | 4856 |
|
|
2021
Q4 | $6K | Hold |
2,400
| – | – | ﹤0.01% | 4131 |
|
|
2021
Q3 | $12K | Sell |
2,400
-2,900
| -55% | -$17.6K | ﹤0.01% | 3813 |
|
|
2021
Q2 | $44K | Buy |
5,300
+2,500
| +89% | +$21.1K | ﹤0.01% | 2603 |
|
|
2021
Q1 | $24K | Buy |
+2,800
| New | +$29K | ﹤0.01% | 3079 |
|
|
2020
Q4 | – | Sell |
-1,100
| Closed | -$13.6K | – | 5737 |
|
|
2020
Q3 | $13K | Sell |
1,100
-500
| -31% | -$6.7K | ﹤0.01% | 2822 |
|
|
2020
Q2 | $25K | Hold |
1,600
| – | – | ﹤0.01% | 2240 |
|
|
2020
Q1 | $24K | Sell |
1,600
-200
| -11% | -$4.29K | ﹤0.01% | 2187 |
|
|
2019
Q4 | $44K | Buy |
+1,800
| New | +$26.7K | ﹤0.01% | 1719 |
|
|
2018
Q2 | – | Sell |
-430
| Closed | -$6.69K | – | 5140 |
|
|
2018
Q1 | $7K | Sell |
430
-3,100
| -88% | -$52.4K | ﹤0.01% | 3097 |
|
|
2017
Q4 | $44K | Buy |
3,530
+3,414
| +2,943% | +$49.6K | ﹤0.01% | 1971 |
|
|
2017
Q3 | $2K | Sell |
116
-7,629
| -99% | -$116K | ﹤0.01% | 5229 |
|
|
2017
Q2 | $116K | Buy |
7,745
+6,445
| +496% | +$97.4K | ﹤0.01% | 1734 |
|
|
2017
Q1 | $22K | Sell |
1,300
-700
| -35% | -$9.32K | ﹤0.01% | 3251 |
|
|
2016
Q4 | $24K | Hold |
2,000
| – | – | ﹤0.01% | 3295 |
|
|
2016
Q3 | $19K | Sell |
2,000
-300
| -13% | -$2.74K | ﹤0.01% | 3493 |
|
|
2016
Q2 | $23K | Buy |
2,300
+500
| +28% | +$5.58K | ﹤0.01% | 3225 |
|
|
2016
Q1 | $21K | Buy |
1,800
+500
| +38% | +$5.06K | ﹤0.01% | 3254 |
|
|
2015
Q4 | $20K | Buy |
+1,300
| New | +$19.3K | ﹤0.01% | 3431 |
|
Other funds holding EPZM
Cutler Group's EPZM Position: Q3 2022 in Review
Cutler Group sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 2,400 shares — an estimated $3K sold.
Cutler Group first reported a position in EPZM in Q4 2015 and held it in 20 quarters. The position peaked at $116K in Q2 2017. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.
- Cutler Group reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
- Cutler Group sold 2,400 Epizyme, Inc shares in Q3 2022, an estimated $3K.
- Cutler Group first reported a position in Epizyme, Inc in Q4 2015 and held it in 20 quarters.
- Cutler Group's Epizyme, Inc position peaked at $116K in Q2 2017.
- 0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.
Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.